Menu Close
The Conversation

Daniel Kelly

6

Articles

6

Comments
Senior Lecturer in Biochemistry, Sheffield Hallam University

Daniel Kelly is a senior lecturer in Biochemistry at Sheffield Hallam University with research interests in cardiovascular disease, type 2 diabetes, obesity and the role of testosterone in these diseases. Following his PhD studying the anti-inflammatory effects of testosterone on atherosclerosis, Daniel undertook a postdoc at the University of Sheffield to work with Professor Hugh Jones to investigate the tissue-specific actions of testosterone related to the pathogenesis of type 2 diabetes and cardiovascular disease. This research continues at Sheffield Hallam University and extends through on-going collaborations with partners at the University of Sheffield, University of Chile, Barnsley NHS foundation trust and Bayer Healthcare where he is currently using cell culture systems, pre-clinical models and medical trials of replacement therapy to uncover the underlying mechanisms of testosterone action. He has published in several high-impact journals in the field of endocrinology and acts as a reviewer for many of these journals. He is associate editor for the journal Androgens:Clinical research and Therapeutics.

Daniel has an honorary lectureship position at the University of Sheffield allowing close collaboration across the Sheffield Universities. He is the deputy course leader for the undergraduate Biomedical Science degree at Sheffield Hallam University where he uses his current and prior research to inform his teaching in areas related to metabolism, endocrinology, cell biology, and biological basis of disease.

Experience

  • 2016–present
    Lecturer, Sheffiedl Hallam University
  • 2011–2016
    Postdoctoral research associate, Univesity of Sheffield

Education

  • 2010 
    Sheffield Hallam University, PhD
  • 2003 
    Aston University, Birmingham, BSc (hons) Human Biology and Psychology

Publications

  • 2018
    Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system., Asian Journal Andrology
  • 2016
    Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissue of the testicular feminised mouse., Endocrine
  • 2015
    Testosterone and Obesity., Obesity Reviews
  • 2014
    Testosterone suppresses regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice. , Life Sciences
  • 2014
    Testosterone and cardiovascular risk in men., Vol. 43 Frontiers of Hormone Research
  • 2013
    Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. , Nature Reviews Endocrinology
  • 2013
    Testosterone: A Metabolic Hormone in Health and Disease., Journal of Endocrinology
  • 2013
    Testosterone: A Vascular Hormone in Health and Disease., Journal of Endocrinology
  • 2012
    Effect of Testosterone on Inflammatory Markers in the Development of Early Atherogenesis in the Testicular-Feminized Mouse Model., Endocrine Research

Grants and Contracts

  • 2018
    Summer studentship
    Role:
    PI
    Funding Source:
    Society for Endocrinology
  • 2016
    Early Career Grant
    Role:
    PI
    Funding Source:
    Society for Endocrinology

Professional Memberships

  • Society for Endocrinology
  • The Endocrine Society